• Search
  • Advanced Search
Clin Mol Hepatol > Accepted Articles
Reply to Correspondence
Reply: Correspondence: “Transcriptomic signature in hepatocellular carcinoma to predict immunotherapy response.”
Hiroaki Kanzaki1,2, Yujin Hoshida2
1Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan
2Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, U.S.
Correspondence :  Yujin Hoshida ,
Email: Yujin.Hoshida@UTSouthwestern.edu
Received: October 8, 2024   Accepted: October 9, 2024
KeyWords: hepatocellular carcinoma; immunotherapy; predictive biomarker; tumor immune microenvironment
TOOLS
METRICS Graph View
  • 0 Crossref
  •  0 Scopus
  • 320 View
  • 11 Download
Related articles

Correspondence on Letter regarding “Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis”

Correspondence on Letter regarding “Transcriptomic signature in advanced hepatocellular carcinoma tissue to predict combination immunotherapy response.”

Correspondence on Editorial regarding “KCTD17 as a RAS stabilizer in hepatocellular carcinoma progression”

Transcriptomic signature in advanced hepatocellular carcinoma tissue to predict combination immunotherapy response

Reply to correspondence on “Severity of microvascular invasion does matter in hepatocellular carcinoma prognosis”2024 October;30(4)

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: cmh_journal@ijpnc.com
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 727
TOTAL : 2237606
Close layer